New compound developed to target triple negative breast cancer
Researchers at the University of Michigan (Ann Arbor, MI, USA) have identified a promising new compound in the search for targeted treatments against one of the most aggressive forms of cancer.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.